EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The CLEC3B inhibits cellular proliferation and metastasis of cholangiocarcinoma through Wnt/β-catenin pathway

Shengze Wu, Guangfeng Wang, Yuwei Xie, Tingting Wu, Fangqian Du, Chen Jin, Bingzi Dong, Chengzhan Zhu

PeerJ · 13.11.2024 · 12 · e18497

DOI: 10.7717/peerj.18497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 13.11.2024. Verfasst von Shengze Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Lectins, C-Type, Cell Proliferation, Bile Duct Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taishan Scholars Program of Shandong Province, Natural Science Foundation of Shandong Province, Shandong Higher Education Young Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cholangiocarcinoma (CCA) is a cancer of the biliary system, including intrahepatic and extrahepatic cholangiocarcinoma, and is highly aggressive. C-type lectins family member 3b (CLEC3B) is a Ca 2+ binding transmembrane protein with different biological functions in a variety of cancers. The objective of this study was to explore the biological function of CLEC3B in CCA.

Methods

The CLEC3B gene was identified using the TCGA database and survival analysis of the cholangiocarcinoma clinical cohort. The expression CLEC3B cholangiocarcinoma and correlation with prognosis was investigated in our patient cohort. The effects of CLEC3B on proliferation, apoptosis, migration and invasion were verified in QBC939 and HUCCT1 cells. The effect of CLEC3B on the tumor formation was proved by xenograft tumor model in nude mice. The signaling pathway of CLEC3B in regulating CCA progression was further analyzed RNA sequencing and western blot.

Results

CLEC3B was decreased in the cholangiocarcinoma in the database. The mRNA and protein expression level of CLEC3B were significantly lower and correlated with poor overall survival in cholangiocarcinoma of our patient cohort. In vitro experiments proved that overexpression of CLEC3B can inhibit proliferation, migration and invasion in bile duct cancer cells. The CLEC3B was correlated with epithelial–mesenchymal transition and apoptosis. The calcium could promote the biological function of CLEC3B. The vivo study indicated that CLEC3B inhibited tumor formation. RNA sequencing indicating CLEC3B may transduce signal through e Wnt/β-catenin signaling pathway.

Conclusions

The CLEC3B inhibits cellular proliferation and migration of cholangiocarcinoma through the Wnt/β-catenin pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaLectins, C-TypeCell ProliferationBile Duct NeoplasmsWnt Signaling PathwayHumansAnimalsMiceCell Line, TumorMice, NudeMaleFemaleCell MovementPrognosisApoptosisGene Expression Regulation, NeoplasticEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

CLEC3BCalciumCholangiocarcinoma (CCA)MigrationProliferation

Substanzen

Lectins, C-Type

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Pediatric Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Förderung

  • Taishan Scholars Program of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Shandong Higher Education Young Science and Technology Support Program

Zitieren

APA

Wu, S., Wang, G., Xie, Y., Wu, T., Du, F., Jin, C., Dong, B., & Zhu, C. (2024). The CLEC3B inhibits cellular proliferation and metastasis of cholangiocarcinoma through Wnt/β-catenin pathway. PeerJ, 12, e18497. https://doi.org/10.7717/peerj.18497

Vancouver

Wu S, Wang G, Xie Y, Wu T, Du F, Jin C, et al. The CLEC3B inhibits cellular proliferation and metastasis of cholangiocarcinoma through Wnt/β-catenin pathway. PeerJ. 2024;12:e18497. doi:10.7717/peerj.18497

BibTeX
@article{Wu2024,
  author = {Wu, Shengze and Wang, Guangfeng and Xie, Yuwei and Wu, Tingting and Du, Fangqian and Jin, Chen and Dong, Bingzi and Zhu, Chengzhan},
  title = {The CLEC3B inhibits cellular proliferation and metastasis of cholangiocarcinoma through Wnt/β-catenin pathway},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e18497},
  doi = {10.7717/peerj.18497}
}
Kostenlos starten →